₹1030.3
0.84%
Low
Day's Volatility:3.60%
High
2.75%
45.54%
Low
52 Weeks Volatility:64.35%
High
18.80%
Returns % | |
1 Month Return | 4.8 % |
3 Month Return | 18.6 % |
1 Year Return | 76.36 % |
Market Stats | |
Previous Close | ₹1,034.35 |
Open | ₹1,026.00 |
Volume | 23.39K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,659.84Cr |
Organisation | Novartis India Ltd |
Headquarters | Mumbai |
Industry | Trading |
E-voting on shares | Click here to vote |
Key events for Novartis India Ltd
Swiss pharmaceutical giant, Novartis, is exploring the sale of its listed unit, Novartis India Limited, while continuing to expand research and development operations in India through its unlisted unit, Novartis Healthcare Private Limited.
Novartis Plans to Sell Stake in Novartis India Limited - 21 Mar, 2024
Novartis CEO Narasimhan has announced that the company plans to sell its 70.6% stake in Novartis India Limited (NIL) to a new owner, while continuing to build on capacity and operations in India through NHPL.
Novartis India to Launch Novel CML Treatment Asciminib - 15 Mar, 2024
Novartis India is set to launch a first-of-its-kind treatment for chronic myeloid leukemia (CML) called Asciminib by the end of March. The company is currently in talks with potential distribution partners, but has not disclosed any specific details about brand partnerships.
Novartis India in Discussions for Distribution Partner for Asciminib Launch - 14 Mar, 2024
Novartis India is in talks to secure a distribution partner for the launch of Asciminib, a first-in-class treatment for chronic myeloid leukemia. The drug targets the ABL myristoyl pocket and is expected to be launched soon.
Fundamentals of Novartis India Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, NOVARTIND stock has moved up by 18.6%
Retail Holding Up
Retail Investor have increased holdings from 28.47% to 28.59% in Dec 2023 quarter
Best in 1 Year
In the last 1 year, NOVARTIND has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.68% of holdings in Dec 2023 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 140.0% return, outperforming this stock by 61.4%
FII Holding Down
Foreign Institutions have decreased holdings from 0.32% to 0.19% in Dec 2023 quarter
Investors | Holdings % | Prev. 4 periods | 3M change |
---|---|---|---|
Promoter Holdings | 70.68% | 0.00 | |
Foreign Institutions | 0.19% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 28.59% | 0.44 | |
Others | 0.53% | 0.06 |
Technicals of Novartis India Ltd share
News & Events of Novartis India Ltd
Novartis India Ltd (500672) share price today is ₹1030.3
Novartis India Ltd is not listed on NSE
Novartis India Ltd is listed on BSE
Today’s traded volume of Novartis India Ltd(500672) is 23.39K.
Today’s market capitalisation of Novartis India Ltd(500672) is ₹1659.84Cr.
Novartis India Ltd(500672 | Price |
---|---|
52 Week High | ₹1224 |
52 Week Low | ₹561.05 |
Novartis India Ltd(500672) share price is ₹1030.3. It is down -15.83% from its 52 Week High price of ₹1224
Novartis India Ltd(500672) share price is ₹1030.3. It is up 83.64% from its 52 Week Low price of ₹561.05
Novartis India Ltd(500672 | Returns |
---|---|
1 Day Returns | -4.05% |
1 Month Returns | 4.8% |
3 Month Returns | 18.6% |
1 Year Returns | 76.36% |